Oslo University Hospital

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Recruiting	Active	Bezuclastinib plus Sunitinib	NCT05208047
4	Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients	Completed	Closed	Imatinib + Sunitinib + Regorafenib	NCT01276483
2	The Stop-GIST Trial: Discontinuation of Imatinib in Patients With Oligo-metastatic GIST	Suspended	Closed	Imatinib	NCT02924714